Inventorship remains the touchstone of who owns patentable technology. Yet inventorship remains, at times, one of the most perplexing and contentious aspects of patent law.
Case in point is the recent 111-page decision in Dana-Faber Cancer Institute, Inc. v. Ono
Michael Best & Friedrich LLP Blogs
Latest from Michael Best & Friedrich LLP
Future Trends on the Doctrine of Equivalents?
Claims of infringement under the doctrine of equivalents routinely accompany literal infringement claims in patent infringement litigation. Likewise, patent prosecutors typically try to avoid narrowing the scope of equivalents during prosecution of a patent application. But, a pair of recent
Future Trends on the Doctrine of Equivalents?
Claims of infringement under the doctrine of equivalents routinely accompany literal infringement claims in patent infringement litigation. Likewise, patent prosecutors typically try to avoid narrowing the scope of equivalents during prosecution of a patent application. But, a pair of recent
Reasonable Expectations of Success and Compound Claims “As a Whole”
Challenges to new molecule patents frequently hinge on the question of obviousness in view of a prior art “lead compound.” More often than not, patentees fend off these challenges by successfully arguing against selection or modification of the asserted lead compound,
Reasonable Expectations of Success and Compound Claims “As a Whole”
Challenges to new molecule patents frequently hinge on the question of obviousness in view of a prior art “lead compound.” More often than not, patentees fend off these challenges by successfully arguing against selection or modification of the asserted lead compound,
False Advertising: The Theory of Necessary Implication and the Presumption that Runs with It
In writing this post, I had hoped to get back to basics and address the elements of a false advertising claim. But when doing so, the proverbial onion layers started to unravel—one of those layers being the theory of necessary
USPTO Subject Matter Eligibility Guidance Does Not Carry the Day in Court
In Cleveland Clinic Foundation v. True Health Diagnostics LLC (nonprecedential), the Federal Circuit affirmed the district court’s order granting defendant’s Rule 12(b)(6) motion to dismiss because the asserted patent claims are invalid under Section 101. The two asserted patents issued
USPTO Subject Matter Eligibility Guidance Does Not Carry the Day in Court
In Cleveland Clinic Foundation v. True Health Diagnostics LLC (nonprecedential), the Federal Circuit affirmed the district court’s order granting defendant’s Rule 12(b)(6) motion to dismiss because the asserted patent claims are invalid under Section 101. The two asserted patents issued
A Good Reminder that Electrical Claims and Specifications Should Focus on the How, not Just the What
In today’s post-Alice landscape, patent practitioners have developed a gut-feeling about patent eligibility that helps them in various aspects of daily life: advising clients regarding asserted patents, developing office action responses, probing questions in invention disclosure meetings, and drafting effective
Join Our Webinar!
Sales of Digital Tokens & ICOs – Securities, Litigation, and Tax Concerns
Join Michael Best Cryptocurrency and Securities attorneys for a complimentary one-hour live webinar from 12:00 – 1:00 PM CST on Tuesday, April 30, 2019.
2018 was (and 2019